Internet-based Emotional Awareness and Expression Therapy for Somatic Symptom Disorder
MBS1
1 other identifier
interventional
50
1 country
1
Brief Summary
The main purpose of the study is to conduct an initial feasibility evaluation of the new Internet-based EAET treatment manual. We will include 50 patients with somatic symptom disorder to take part of the treatment for nine weeks through the Internet. A within-subject design will be used. Self-report measures of symptom level and mechanisms of change will be conducted weekly. Feedback on content, process and potential caveats will be collected using surveys and written evaluations from the participants at post-treatment. Linear mixed models will be used to investigate trajectories of change in symptoms and processes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2019
CompletedFirst Submitted
Initial submission to the registry
October 4, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedApril 16, 2020
April 1, 2020
6 months
October 4, 2019
April 15, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
PHQ-15
Patient Health Questionnaire Physical Symptoms
Baseline
PHQ-15
Change in physical symptoms (as measured by the PHQ-15)
Weekly during treatment, for 9 weeks
PHQ-15
Patient Health Questionnaire Physical Symptoms
At study completion, after 9 weeks
PHQ-15
Patient Health Questionnaire Physical Symptoms
At study completion, after 4 months
Secondary Outcomes (9)
PHQ-9
Baseline
PHQ-9
At study completion, after 9 weeks
PHQ-9
At study completion, after 4 months
GAD-7
Baseline
GAD-7
At study completion, after 9 weeks
- +4 more secondary outcomes
Other Outcomes (4)
EPS-25
Baseline
EPS-25
Weekly during treatment, for 9 weeks
EPS-25
At study completion, after 9 weeks
- +1 more other outcomes
Study Arms (1)
Treatment (Emotional Awareness and Expression Therapy)
EXPERIMENTALInternet-based Emotional Awareness and Expression Therapy
Interventions
Very much based on "Unlearn your pain" by Howard Schubiner.
Eligibility Criteria
You may qualify if:
- Age over 18 years
- A total score ≥10 on the PHQ-15
- A diagnosis of SSD according to the DSM-5, i.e ≥1 of the 3 of: disproportionate thoughts about the somatic symtom, persistently high level of anxiety, or excessive time and energy devoted in regard to symptoms or health concerns
- Symptom duration ≥6 months
- Written statement from a medical professional that states that a medical evaluation has been conducted.
You may not qualify if:
- Alcohol or substance addiction
- A diagnosis of a psychological condition that might require other treatment (e.g., psychosis, suicidality, etc)
- Other severe medical condition that might require other treatment
- Ongoing psychological intervention or psychotherapy that may interfere with the psychological treatment
- Ongoing medical treatment that may interfere with the psychological treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Stockholm Universitycollaborator
Study Sites (1)
Karolinska Institutet
Stockholm, Sweden
Related Publications (1)
Maroti D, Ek J, Widlund RM, Schubiner H, Lumley MA, Lilliengren P, Bileviciute-Ljungar I, Ljotsson B, Johansson R. Internet-Administered Emotional Awareness and Expression Therapy for Somatic Symptom Disorder With Centralized Symptoms: A Preliminary Efficacy Trial. Front Psychiatry. 2021 Feb 12;12:620359. doi: 10.3389/fpsyt.2021.620359. eCollection 2021.
PMID: 33679478DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Johansson, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 4, 2019
First Posted
October 10, 2019
Study Start
September 30, 2019
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
April 16, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share